Patents Assigned to Altermune Technologies, LLC
  • Chemically programmable immunity
    Patent number: 8591910
    Abstract: The present invention is related to methods and compositions that are capable of immediately immunizing a human or animal against any molecule or compound. The present invention comprises an immunity linker molecule with at least two sites; (1) a first binding site that binds to an immune system molecule in a human or animal that has been preimmunized against the first binding site, and (2) one or more second binding sites that bind specifically to a desired compound or molecule. The first binding site and the second binding site(s) are linked by a linker portion of the molecule.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: November 26, 2013
    Assignee: Altermune Technologies LLC
    Inventor: Kary B. Mullis
  • Chemically programmable immunity
    Patent number: 8263082
    Abstract: Methods and compositions for immediately immunizing an individual against any molecule or compound. The present invention comprises an immunity linker with at least two sites; (1) at least one first binding site that binds to an immune response component in an individual that has been pre-immunized with a universal immunogen, and (2) at least one second binding site that binds specifically to a desired compound or molecule, the target.
    Type: Grant
    Filed: January 11, 2010
    Date of Patent: September 11, 2012
    Assignee: Altermune Technologies LLC
    Inventor: Kary Mullis
  • Chemically programmable immunity
    Patent number: 8236321
    Abstract: The present invention is related to methods and compositions that are capable of immediately immunizing a human or animal against any molecule or compound. The present invention comprises an immunity linker molecule with at least two sites; (1) a first binding site that binds to an immune system molecule in a human or animal that has been preimmunized against the first binding site, and (2) one or more second binding sites that bind specifically to a desired compound or molecule. The first binding site and the second binding site(s) are linked by a linker portion of the molecule.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: August 7, 2012
    Assignee: Altermune Technologies, LLC
    Inventor: Kary B. Mullis
  • Chemically programmable immunity
    Patent number: 7850975
    Abstract: The present invention is related to methods and compositions that are capable of immediately immunizing a human or animal against any molecule or compound. The present invention comprises an immunity linker molecule with at least two sites; (1) a first binding site that binds to an immune system molecule in a human or animal that has been preimmunized against the first binding site, and (2) one or more second binding sites that bind specifically to a desired compound or molecule. The first binding site and the second binding site(s) are linked by a linker portion of the molecule.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: December 14, 2010
    Assignee: Altermune Technologies, LLC
    Inventor: Kary B. Mullis